Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial

Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial

Background: The aim was to evaluate the reinforcement of the standard therapy with hyperimmune plasma (HP) in Coronavirus-19 disease (COVID-19) patients. Methods: Open-label, multicenter, randomized clinical trial performed in three hospitals in the Balearic Islands. Non-severe COVID-19 hospitalized...

Full description

Bibliographic Details
Main Authors: Joan Bargay-Lleonart, Fiorella Sarubbo, Maria Arrizabalaga, José Maria Guerra, Josep Borràs, Khaoulah El Haji, Magdalena Flexas, Jorge Perales, Victoria Fernández-Baca, Carmen Gallegos, Manuel Raya Cruz, Sonia Velasco, Víctor López, Ana Cruz, Antonia Bautista-Gili, Teresa Jimenez-Marco, Enric Girona-Llobera, Laia Vilaplana, Laura Calonge, Juan Tena, Maria Pilar Galán, Antoni Payeras
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
hyperimmune plasma
convalescent plasma
donors
antibody
randomized clinical trial
Online Access:https://www.mdpi.com/2077-0383/11/11/3039

Internet

https://www.mdpi.com/2077-0383/11/11/3039

Similar Items